Physician profile
Todd E Erickson
NPI 1497705917
$3,755.09
in general payments reported to CMS, 2019-2025
16 companies · $609 in 2025
The $609 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $171 · 2021: $272 · 2022: $608 · 2023: $663 · 2024: $467 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558 · Entertainment: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.15 |
| Entertainment | $180.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $928.07 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $853.54 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $612.09 | 2022-2025 | Infuse, Infuse Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $404.89 | 2019-2021 | |
| Optos, INC. | $248.71 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $114.13 | 2019 | |
| Horizon Therapeutics Plc | $111.84 | 2022 | |
| Coopervision INC. | $108.06 | 2019-2025 | Myday Contact Lens |
| Genentech USA, INC. | $108.02 | 2019 | |
| Lkc Technologies, INC. | $98.93 | 2024 | |
| Rxsight INC | $57.69 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Tarsus Pharmaceuticals, INC. | $25.86 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $22.05 | 2020 | |
| Oyster Point Pharma, INC. | $21.93 | 2022 | |
| Eyevance Pharmaceuticals LLC | $21.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.